Additive value: Inside GE Healthcare’s 3D printing and design lab

By Dan Stanton contact

- Last updated on GMT

GE Healthcare opened its European Innovative Design and Advanced Manufacturing Technology Center last month. Biopharma-Reporter took a visit to Uppsala, Sweden to find out more.

As part of a press trip to GE Healthcare’s R&D and manufacturing site in Uppsala, Sweden, Biopharma-Reporter was invited to find out more about the Innovative Design and Advanced Manufacturing Technology Center which opened its doors last month​.

The life sciences vendor is developing additive manufacturing – commonly known as 3D printing – and robotic technologies for the production of bioprocessing tools and equipment.

The facility is equipped with a metal and a polymer industrial grade 3D printer, along with a heat bonding machine, and traditional manufacturing equipment. Several collaborative robots (known as ‘cobots’) will also be developed in the lab then transferred to the factories that need them.

Among the projects underway, the firm is working with Amgen to test the performance of a custom-designed 3D printed chromatography column.

GE is expecting to start integrating the technology into its bioprocessing offerings from 2018.

Related news

Show more

Related products

show more

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Viral Safety for mAb: Prevent, Detect, Remove | 23-Nov-2020 | Technical / White Paper

This white paper explores the factors driving the evolution toward faster biosafety testing and describes rapid approaches for adventitious agent testing...

Blazar™ Platform: Rodent Virus Panel

Blazar™ Platform: Rodent Virus Panel

Viral Safety for mAb: Prevent, Detect, Remove | 16-Nov-2020 | Technical / White Paper

We have a long history of developing innovative molecular technologies for cell line characterization and lot release testing for the biopharmaceutical...

Monitoring SARS-CoV-2 interaction with ACE2

Monitoring SARS-CoV-2 interaction with ACE2

Take the Right Path Upstream with MilliporeSigma | 02-Nov-2020 | Technical / White Paper

In this technical note, we investigate the interactions between the following: The spike glycoprotein binding with ACE2, Spike glycoprotein and anti-spike...

Related suppliers

Follow us

Products

View more

Webinars